Source: Virtual Congress 2020 – Diagnostic characteristics and consequences of sleep and breathing disorders
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
T. Gaisl (Zürich, Switzerland), R. Protazy (Zürich, Switzerland), M. Roeder (Zürich, Switzerland), P. Baumgartner (Zürich, Switzerland), N. Sievi (Zürich, Switzerland), S. Siegfried (Zürich, Switzerland), S. Stämpfli (Lucerne, Switzerland), F. Tanner (Zürich, Switzerland), M. Kohler (Zürich, Switzerland). Is obstructive sleep apnea a risk factor for the progression of thoracic aortic aneurysm? A prospective cohort study. 4991

Member's Comments

No comment yet.

Related content which might interest you: Is obstructive sleep apnea a risk factor for the progression of thoracic aortic aneurysm? A prospective cohort study. Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities Year: 2018 Prevalence of obstructive sleep apnoea in patients with thoracic aortic aneurysm: A prospective, parallel cohort study. Source: International Congress 2019 – Epidemiology, genetics, air pollution and sleep Year: 2019 Obstructive sleep apnoea and the progression of thoracic aortic aneurysm: a prospective cohort study Source: Eur Respir J, 57 (5) 2003322; 10.1183/13993003.03322-2020 Year: 2021 High obstructive sleep apnea risk in patients with type A aortic dissection Source: International Congress 2018 – Obesity: comorbidities Year: 2018 Thoracic aortic aneurysms: expanding the potential cardiovascular consequences of obstructive sleep apnoea Source: Eur Respir J, 57 (5) 2004440; 10.1183/13993003.04440-2020 Year: 2021 Increased incidence of coronary artery disease in obstructive sleep apnoea: a seven-year follow-up Source: Eur Respir J 2001; 18: Suppl. 33, 518s Year: 2001 Prevalence of cardiovascular risk factors and coronary artery disease in patients with obstructive sleep apnea syndrome (OSAS) requiring CPAP treatment Source: Eur Respir J 2006; 28: Suppl. 50, 814s Year: 2006 High prevalence of obstructive sleep apnoea in revascularized patients with coronary artery disease – RICCADSA trial Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008 Treatment of obstructive sleep apnea improves cardiovascular outcome. A prospective study Source: Eur Respir J 2006; 28: Suppl. 50, 817s Year: 2006 Prevalence of obstructive sleep apnoea and its association with aortic root dilatation in patients with Marfan‘s syndrome Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008 Is acute pulmonary embolism more severe in the presence of obstructive sleep apnoea? Results from a cohort study. Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities Year: 2017 Gout increases the risk of coronary heart disease among patients with obstructive sleep apnea: A nationwide population-based cohort study Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity Year: 2015 Cardiovascular outcomes in patients with coronary artery disease and nonsleepy versus sleepy obstructive sleep apnoea phenotypes in the RICCADSA trial Source: Virtual Congress 2021 – The different faces of sleep disturbances in respiratory diseases and beyond Year: 2021 Clinical and polysomnographic determinants of REM predominant obstructive sleep apnoea and response to treatment in a revascularized coronary artery disease cohort Source: Virtual Congress 2020 – Diagnostic characteristics and consequences of sleep and breathing disorders Year: 2020 Association between obstructive sleep apnoea (OSA) and risk of systemic hypertension in men. A prospective study Source: Eur Respir J 2003; 22: Suppl. 45, 22s Year: 2003 CPAP does not reduce inflammatory biomarkers in coronary artery disease patients with nonsleepy obstructive sleep apnoea: a randomized controlled trial Source: International Congress 2017 – CPAP therapy Year: 2017 Apolipoprotein E polymorphisms and incident arterial hypertension in obstructive sleep apnea patients A prospective cohort study Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality Year: 2018 Assessment of aortic stiffness which is a new cardiovascular morbidity and mortality predictor in patients with obstructive sleep apnea syndrome and relation with severity of the disease Source: Eur Respir J 2006; 28: Suppl. 50, 814s Year: 2006 Natural course of untreated obstructive sleep apnoea in patients with coronary artery disease in the RICCADSA trial Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing Year: 2021 Adherence to CPAP treatment in patients with coronary artery disease and obstructive sleep apnoea without sleepiness: a preliminary report from the riccadsa trial Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009